Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Europe (Supplemental) | 2025

The European EP mapping and ablation device market will experience strong growth through 2033, driven
by the increasing prevalence of cardiac arrhythmia in Europe, improved access to treatment, advancements
in ablation and diagnostic technologies, favorable clinical guidelines supporting cardiac ablation, and
clinical evidence supporting the uptake of premium-priced devices.
 

Related Medtech Insights Reports

Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative, higher-priced powered thrombectomy devices and their increasing adoption for treating PE—supported by favorable clinical data—will drive strong growth in the global…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2035, driven by the rapid expansion of AF ablation procedures, particularly PFA devices, and the approval of…